1. Home
  2. SHIM vs HUMA Comparison

SHIM vs HUMA Comparison

Compare SHIM & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

HOLD

Current Price

$2.44

Market Cap

128.6M

Sector

N/A

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.43

Market Cap

165.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHIM
HUMA
Founded
1990
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.6M
165.7M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
SHIM
HUMA
Price
$2.44
$0.43
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
★ $7.00
$1.63
AVG Volume (30 Days)
130.1K
★ 5.6M
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 81.95
79.37
EPS
N/A
N/A
Revenue
★ $492,844,000.00
$2,038,000.00
Revenue This Year
$1.41
$72.32
Revenue Next Year
$20.36
$518.79
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 2.63
N/A
52 Week Low
$1.95
$0.34
52 Week High
$6.76
$1.90

Technical Indicators

Market Signals
Indicator
SHIM
HUMA
Relative Strength Index (RSI) 26.98 39.73
Support Level N/A N/A
Resistance Level $4.09 $0.75
Average True Range (ATR) 0.20 0.04
MACD -0.05 -0.00
Stochastic Oscillator 2.13 47.46

Price Performance

Historical Comparison
SHIM
HUMA

About SHIM Shimmick Corporation

Shimmick Corp is engaged in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resiliency, and sustainable transportation. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains critical infrastructure, including mass transit, bridges, and military infrastructure. The company has one operating and reportable segment: infrastructure solutions. All of its revenue is derived from the United States.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: